Patents by Inventor Masahiko Morita

Masahiko Morita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965510
    Abstract: A compressor body includes a compression mechanism including a screw rotor that compresses gas, a casing that accommodates the compression mechanism and defines a compression working chambers therein, a suction side bearing that rotatably supports the screw rotor, a bearing chamber that accommodates the suction side bearing, and a liquid supply port that communicates with the compression working chambers and supplies liquid supplied from the outside of the casing into the compression working chambers. The casing has an internal liquid supply flow path that extends from a discharge side of the compression working chambers as an upstream side to a suction side of the compression working chambers as a downstream side and that supplies the liquid to the liquid supply port. The internal liquid supply flow path has a downstream portion reaching the bearing chamber and supplies the liquid to the suction side bearing.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: April 23, 2024
    Assignee: Hitachi Industrial Equipment Systems Co., Ltd.
    Inventors: Shigeyuki Yorikane, Masahiko Takano, Kenji Morita, Yoshitaka Takeuchi
  • Patent number: 11738037
    Abstract: An object of the invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.
    Type: Grant
    Filed: December 30, 2020
    Date of Patent: August 29, 2023
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
  • Publication number: 20230263761
    Abstract: An agent for elevating nitric oxide (NO) concentration comprising glutathione or a salt thereof as an active ingredient; an agent for elevating NO concentration comprising glutathione or a salt thereof as an active ingredient for preventing or ameliorating a vascular endothelial malfunction-related symptom, or dilating blood vessels or promoting blood flow by elevating NO concentration; and a method for elevating NO concentration by ingesting glutathione or a salt thereof.
    Type: Application
    Filed: April 11, 2023
    Publication date: August 24, 2023
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Masahiko MORITA, Ayako KAMIMURA
  • Publication number: 20230181614
    Abstract: The invention provides a method for improving attention of a healthy human subject by administering an effective amount of citidine-5?-diphosphocholine or a salt thereof to a healthy human subject.
    Type: Application
    Filed: December 21, 2022
    Publication date: June 15, 2023
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
  • Patent number: 11654125
    Abstract: An agent for elevating nitric oxide (NO) concentration comprising glutathione or a salt thereof as an active ingredient; an agent for elevating NO concentration comprising glutathione or a salt thereof as an active ingredient for preventing or ameliorating a vascular endothelial malfunction-related symptom, or dilating blood vessels or promoting blood flow by elevating NO concentration; and a method for elevating NO concentration by ingesting glutathione or a salt thereof.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: May 23, 2023
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Masahiko Morita, Ayako Kamimura
  • Patent number: 11583546
    Abstract: A method of improving both motor function and cognitive function of healthy human subjects through administration of citicoline or its salt in high dosage or low dosage for a period of time, resulting in improved motor function and cognitive function.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: February 21, 2023
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
  • Publication number: 20210113601
    Abstract: An object of the invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.
    Type: Application
    Filed: December 30, 2020
    Publication date: April 22, 2021
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Kota KUMAGAI, Masahiko MORITA, Takahiro HARA, Kohji FUKUNAGA
  • Patent number: 10905705
    Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: February 2, 2021
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
  • Publication number: 20200108034
    Abstract: The invention provides citrulline or a salt thereof and glutathione or a salt thereof for use in increasing a ratio of muscle mass to total body weight in a person in conjunction with a resistance workout program, as well as a method of increasing a ratio of muscle mass to total body weight in a person by administering citrulline or a salt thereof and glutathione or a salt thereof to the person in conjunction with a resistance workout program. The citrulline and glutathione or salts thereof are administered daily for a period greater than 7 days, whereas the resistance workout program is administered for at least the entire period during which the two compounds are administered. The muscle mass is measured by a body composition meter.
    Type: Application
    Filed: May 31, 2018
    Publication date: April 9, 2020
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Masahiko MORITA, Ayako KAMIMURA, Darryn S. WILLOUGHBY
  • Patent number: 10369186
    Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients is provided.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: August 6, 2019
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
  • Patent number: 9833426
    Abstract: An agent for enhancing NO production, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: December 5, 2017
    Assignee: Kyowa Hakko Bio Co., Ltd.
    Inventors: Masahiko Morita, Miho Yin Komatsu, Takahiro Hara
  • Publication number: 20170049796
    Abstract: A method of improving both motor function and cognitive function of healthy human subjects through administration of citicoline or its salt in high dosage or low dosage for a period of time, resulting in improved motor function and cognitive function.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
  • Publication number: 20170042962
    Abstract: An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved NO production enhancing effect is provided. A NO production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Inventors: Masahiko Morita, Miho Komatsu, Takahiro Hara
  • Patent number: 9480668
    Abstract: The present invention provides a blood flow promoting agent containing citrulline or a salt thereof and capsaicin or capsaicinoids as active ingredients, which is safe even by long-term administration, a food with health claims and a functional food affording such action, particularly, a blood flow promoting agent exhibiting an effective vasodilatory action of capsaicin at a low dose free of irritant property, which can be applied to improvement of athletic performance exhibited in relation to peripheral vasodilatation, suppression of fat accumulation, improvement of skin quality, as well as securing blood circulation in ischemic disease and the like, relaxation of blood vessel biased to coarctation due to advancing age, lifestyle-related diseases and the like, prophylaxis of arteriosclerosis, and prophylaxis of stiff neck, feeling of cold, erectile dysfunction, thrombosis and the like due to blood flow disorder.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: November 1, 2016
    Assignee: Kyowa Hakko Bio Co., Ltd.
    Inventors: Masahiko Morita, Ayako Kamimura, Yoshinori Kobayashi
  • Publication number: 20160296586
    Abstract: An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved NO production enhancing effect is provided. A NO production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.
    Type: Application
    Filed: June 21, 2016
    Publication date: October 13, 2016
    Inventors: Masahiko Morita, Miho Komatsu, Takahiro Hara
  • Patent number: 9420223
    Abstract: An image recording device capable of obtaining a moving image with less noise even in a low illuminance environment when obtaining a moving image having a wide dynamic range. An image pickup device picks up an image of an object over different exposure time periods to output a plurality of image signals. The plurality of image signals output from the image pickup device are synthesized to thereby obtain a synthesized image. The synthesized image is recorded in a memory at a predetermined frame rate. Respective vertical transfer periods for reading out the plurality of image signals are differentiated according to the different exposure time periods, and the sum of the vertical transfer periods is controlled to a time period defined by the predetermined frame rate.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: August 16, 2016
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Masahiko Morita
  • Patent number: 9392954
    Abstract: A classification estimating system can include an input element group; an intermediate element group into which are input values of first intermediate variables for which a first multiple desensitization, including an accumulation of values of each input element of a first input element group and each value of a first output sensitivity and each value of a first multiplex output sensitivity, has been carried out and calculated; an output element group into which is input a value of an output variable calculated based on a value of each intermediate element of a first intermediate element group and a value of each connection weight; a classification information estimating module for estimating classification information based on pre-stored correspondence relationship information and a value of the output variable; and a classification information display.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: July 19, 2016
    Assignee: University of Tsukuba
    Inventors: Masahiko Morita, Hiroshi Kawata
  • Publication number: 20150352067
    Abstract: An agent for elevating nitric oxide (NO) concentration comprising glutathione or a salt thereof as an active ingredient; an agent for elevating NO concentration comprising glutathione or a salt thereof as an active ingredient for preventing or ameliorating a vascular endothelial malfunction-related symptom, or dilating blood vessels or promoting blood flow by elevating NO concentration; and a method for elevating NO concentration by ingesting glutathione or a salt thereof.
    Type: Application
    Filed: January 21, 2014
    Publication date: December 10, 2015
    Inventors: Masahiko MORITA, Ayako KAMIMURA
  • Publication number: 20150306125
    Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.
    Type: Application
    Filed: October 30, 2013
    Publication date: October 29, 2015
    Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
  • Publication number: 20150297546
    Abstract: The present invention provides a blood flow promoting agent containing citrulline or a salt thereof and capsaicin or capsaicinoids as active ingredients, which is safe even by long-term administration, a food with health claims and a functional food affording such action, particularly, a blood flow promoting agent exhibiting an effective vasodilatory action of capsaicin at a low dose free of irritant property, which can be applied to improvement of athletic performance exhibited in relation to peripheral vasodilatation, suppression of fat accumulation, improvement of skin quality, as well as securing blood circulation in ischemic disease and the like, relaxation of blood vessel biased to coarctation due to advancing age, lifestyle-related diseases and the like, prophylaxis of arteriosclerosis, and prophylaxis of stiff neck, feeling of cold, erectile dysfunction, thrombosis and the like due to blood flow disorder.
    Type: Application
    Filed: November 5, 2013
    Publication date: October 22, 2015
    Inventors: Masahiko MORITA, Ayako KAMIMURA, Yoshinori KOBAYASHI